{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:32:04Z","timestamp":1782916324645,"version":"3.54.5"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12028-025-02383-1","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:51:40Z","timestamp":1760374300000},"page":"666-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Role of Alpha Lipoic Acid in the Treatment of Traumatic Brain Injury: Pathways and Perspectives"],"prefix":"10.1007","volume":"44","author":[{"given":"Mazyar","family":"Ataei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Peyrovinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moloud","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedieh Sadat","family":"Shamsnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Mohaghegh Shalmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-9097","authenticated-orcid":false,"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"1","key":"2383_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2040-7378-2-16","volume":"2","author":"C Albert-Weissenberger","year":"2010","unstructured":"Albert-Weissenberger C, Sir\u00e9n AL. Experimental traumatic brain injury. Exp Transl Stroke Med. 2010;2(1):16.","journal-title":"Exp Transl Stroke Med"},{"issue":"2","key":"2383_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am. 2020;104(2):213\u201338.","journal-title":"Med Clin North Am"},{"issue":"7","key":"2383_CR3","doi-asserted-by":"publisher","first-page":"e14848","DOI":"10.1111\/cns.14848","volume":"30","author":"R Ding","year":"2024","unstructured":"Ding R, Deng M, Wei H, Zhang Y, Wei L, Jiang G, et al. Machine learning-based prediction of clinical outcomes after traumatic brain injury: hidden information of early physiological time series. CNS Neurosci Ther. 2024;30(7):e14848.","journal-title":"CNS Neurosci Ther"},{"key":"2383_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.wneu.2024.03.175","volume":"187","author":"W Valentim","year":"2024","unstructured":"Valentim W, Bertani R, Brasil S. A narrative review on financial challenges and health care costs associated with traumatic brain injury in the United States. World Neurosurg. 2024;187:82\u201392.","journal-title":"World Neurosurg"},{"key":"2383_CR5","unstructured":"Maas AI, Menon DK, Manley GT, Abrams M, \u00c5kerlund C, Andelic N, et al.; InTBIR Participants and Investigators. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol. 2022 Nov;21(11):1004\u201360"},{"issue":"7","key":"2383_CR6","doi-asserted-by":"publisher","first-page":"e055986","DOI":"10.1136\/bmjopen-2021-055986","volume":"12","author":"VP Matei","year":"2022","unstructured":"Matei VP, Rosca AE, Pavel AN, Paun RM, Gmel G, Daeppen JB, et al. Risk factors and consequences of traumatic brain injury in a Swiss male population cohort. BMJ Open. 2022;12(7):e055986.","journal-title":"BMJ Open"},{"issue":"1","key":"2383_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s40001-022-00897-4","volume":"27","author":"N Gharizadeh","year":"2022","unstructured":"Gharizadeh N, Ghojazadeh M, Naseri A, Dolati S, Tarighat F, Soleimanpour H. Hypertonic saline for traumatic brain injury: a systematic review and meta-analysis. Eur J Med Res. 2022;27(1):254.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2383_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nurt.2009.10.021","volume":"7","author":"ED Hall","year":"2010","unstructured":"Hall ED, Vaishnav RA, Mustafa AG. Antioxidant therapies for traumatic brain injury. Neurotherapeutics. 2010;7(1):51\u201361.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"2383_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/ACO.0000000000001171","volume":"35","author":"P Schober","year":"2022","unstructured":"Schober P, Loer SA, Schwarte LA. Antifibrinolytics in the treatment of traumatic brain injury. Curr Opin Anaesthesiol. 2022;35(5):583\u201392.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"2383_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2011.566489","volume":"43","author":"DG Amen","year":"2011","unstructured":"Amen DG, Wu JC, Taylor D, Willeumier K. Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs. 2011;43(1):1\u20135.","journal-title":"J Psychoactive Drugs"},{"key":"2383_CR11","doi-asserted-by":"publisher","first-page":"1371213","DOI":"10.3389\/fncel.2024.1371213","volume":"18","author":"A Fesharaki-Zadeh","year":"2024","unstructured":"Fesharaki-Zadeh A, Datta D. An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms. Front Cell Neurosci. 2024;18:1371213.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"2383_CR12","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/ijms25042372","volume":"25","author":"S Silvestro","year":"2024","unstructured":"Silvestro S, Raffaele I, Quartarone A, Mazzon E. Innovative insights into traumatic brain injuries: biomarkers and new pharmacological targets. Int J Mol Sci. 2024;25(4):2372.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2383_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/antiox9040297","volume":"9","author":"R Crupi","year":"2020","unstructured":"Crupi R, Cordaro M, Cuzzocrea S, Impellizzeri D. Management of traumatic brain injury: from present to future. Antioxidants. 2020;9(4):297.","journal-title":"Antioxidants"},{"issue":"10","key":"2383_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/antiox9100943","volume":"9","author":"H Ismail","year":"2020","unstructured":"Ismail H, Shakkour Z, Tabet M, Abdelhady S, Kobaisi A, Abedi R, et al. Traumatic brain injury: oxidative stress and novel anti-oxidants such as Mitoquinone and Edaravone. Antioxidants. 2020;9(10):943.","journal-title":"Antioxidants"},{"issue":"21","key":"2383_CR15","doi-asserted-by":"publisher","first-page":"13000","DOI":"10.3390\/ijms232113000","volume":"23","author":"A Fesharaki-Zadeh","year":"2022","unstructured":"Fesharaki-Zadeh A. Oxidative stress in traumatic brain injury. Int J Mol Sci. 2022;23(21):13000.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2383_CR16","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/ani11051454","volume":"11","author":"RM Anthony","year":"2021","unstructured":"Anthony RM, MacLeay JM, Gross KL. Alpha-lipoic acid as a nutritive supplement for humans and animals: an overview of its use in dog food. Animals. 2021;11(5):1454.","journal-title":"Animals"},{"issue":"1","key":"2383_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12906-024-04547-6","volume":"24","author":"P Roy","year":"2024","unstructured":"Roy P, Tomassoni D, Martinelli I, Bellitto V, Nittari G, Amenta F, et al. Protective effects of the R-(+)-thioctic acid treatment: possible anti-inflammatory activity on heart of hypertensive rats. BMC Complement Med Ther. 2024;24(1):281.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"2383_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/ijms22010403","volume":"22","author":"F T\u00f3th","year":"2021","unstructured":"T\u00f3th F, Cseh EK, V\u00e9csei L. Natural molecules and neuroprotection: kynurenic acid, pantethine and \u03b1-lipoic acid. Int J Mol Sci. 2021;22(1):403.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2383_CR19","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/brainsci11081044","volume":"11","author":"C Daia","year":"2021","unstructured":"Daia C, Scheau C, Spinu A, Andone I, Popescu C, Toader C, et al. Modulated neuroprotection in unresponsive wakefulness syndrome after severe traumatic brain injury. Brain Sci. 2021;11(8):1044.","journal-title":"Brain Sci"},{"key":"2383_CR20","doi-asserted-by":"publisher","first-page":"521939","DOI":"10.1155\/2013\/521939","volume":"2013","author":"B Rocamonde","year":"2013","unstructured":"Rocamonde B, Paradells S, Barcia C, Garcia Esparza A, Soria JM. Lipoic acid treatment after brain injury: study of the glial reaction. Clin Dev Immunol. 2013;2013:521939.","journal-title":"Clin Dev Immunol"},{"issue":"8","key":"2383_CR21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","volume":"16","author":"P Kaur","year":"2018","unstructured":"Kaur P, Sharma S. Recent advances in pathophysiology of traumatic brain injury. Curr Neuropharmacol. 2018;16(8):1224\u201338.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"2383_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40473-025-00300-6","volume":"12","author":"M Kumar","year":"2025","unstructured":"Kumar M, Chaudhary J, Jain A. The intricacy of subsequent pathway resulting from traumatic brain injury: pathophysiology and possible interventions. Curr Behav Neurosci Rep. 2025;12(1):7.","journal-title":"Curr Behav Neurosci Rep"},{"issue":"17","key":"2383_CR23","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.3390\/ijms23179628","volume":"23","author":"BF Gruenbaum","year":"2022","unstructured":"Gruenbaum BF, Zlotnik A, Fleidervish I, Frenkel A, Boyko M. Glutamate neurotoxicity and destruction of the blood\u2013brain barrier: key pathways for the development of neuropsychiatric consequences of TBI and their potential treatment strategies. Int J Mol Sci. 2022;23(17):9628.","journal-title":"Int J Mol Sci"},{"key":"2383_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnmol.2019.00020","volume":"12","author":"R Crupi","year":"2019","unstructured":"Crupi R, Impellizzeri D, Cuzzocrea S. Role of metabotropic glutamate receptors in neurological disorders. Front Mol Neurosci. 2019;12:20.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"2383_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1742-4658.2005.05103.x","volume":"273","author":"C Chinopoulos","year":"2006","unstructured":"Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J. 2006;273(3):433\u201350.","journal-title":"FEBS J"},{"issue":"4","key":"2383_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/cells11040706","volume":"11","author":"AY Baev","year":"2022","unstructured":"Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY. Interaction of mitochondrial calcium and ROS in neurodegeneration. Cells. 2022;11(4):706.","journal-title":"Cells"},{"issue":"6","key":"2383_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/WCO.0000000000000763","volume":"32","author":"VE Koliatsos","year":"2019","unstructured":"Koliatsos VE, Alexandris AS. Wallerian degeneration as a therapeutic target in traumatic brain injury. Curr Opin Neurol. 2019;32(6):786\u201395.","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"2383_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/glia.10315","volume":"46","author":"A Sandvig","year":"2004","unstructured":"Sandvig A, Berry M, Barrett LB, Butt A, Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia. 2004;46(3):225\u201351.","journal-title":"Glia"},{"issue":"10","key":"2383_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1089\/neu.2000.17.927","volume":"17","author":"R Raghupathi","year":"2000","unstructured":"Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma. 2000;17(10):927\u201338.","journal-title":"J Neurotrauma"},{"issue":"24","key":"2383_CR30","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.3390\/ijms232415699","volume":"23","author":"S Taheri","year":"2022","unstructured":"Taheri S, Karaca Z, Mehmetbeyoglu E, Hamurcu Z, Yilmaz Z, Dal F, et al. The role of apoptosis and autophagy in the Hypothalamic-Pituitary-Adrenal (HPA) axis after traumatic brain injury (TBI). Int J Mol Sci. 2022;23(24):15699.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2383_CR31","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jcp.29173","volume":"235","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Zhang Y, Jiang W, He L, Qu H. Modulation of autophagy in traumatic brain injury. J Cell Physiol. 2020;235(3):1973\u201385.","journal-title":"J Cell Physiol"},{"key":"2383_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AY. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"2383_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nec.2016.06.002","volume":"27","author":"MJ McGinn","year":"2016","unstructured":"McGinn MJ, Povlishock JT. Pathophysiology of traumatic brain injury. Neurosurg Clin N Am. 2016;27(4):397\u2013407.","journal-title":"Neurosurg Clin N Am"},{"issue":"6","key":"2383_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1517\/13543784.2015.1021919","volume":"24","author":"Y Xiong","year":"2015","unstructured":"Xiong Y, Zhang Y, Mahmood A, Chopp M. Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs. 2015;24(6):743\u201360.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"2383_CR35","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.2174\/1570159X19666210215123914","volume":"19","author":"N Khatri","year":"2021","unstructured":"Khatri N, Sumadhura B, Kumar S, Kaundal RK, Sharma S, Datusalia AK. The complexity of secondary cascade consequent to traumatic brain injury: pathobiology and potential treatments. Curr Neuropharmacol. 2021;19(11):1984\u20132011.","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"2383_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/biomedicines8100389","volume":"8","author":"A Jarrahi","year":"2020","unstructured":"Jarrahi A, Braun M, Ahluwalia M, Gupta RV, Wilson M, Munie S, et al. Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions. Biomedicines. 2020;8(10):389.","journal-title":"Biomedicines"},{"issue":"6","key":"2383_CR37","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s13311-023-01426-9","volume":"20","author":"PJ Bergold","year":"2023","unstructured":"Bergold PJ, Furhang R, Lawless S. Treating traumatic brain injury with minocycline. Neurotherapeutics. 2023;20(6):1546\u201364.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2383_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","volume":"227","author":"A Sauerbeck","year":"2011","unstructured":"Sauerbeck A, Gao J, Readnower R, Liu M, Pauly JR, Bing G, et al. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp Neurol. 2011;227(1):128\u201335.","journal-title":"Exp Neurol"},{"issue":"1","key":"2383_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nurt.2008.10.029","volume":"6","author":"B Stoica","year":"2009","unstructured":"Stoica B, Byrnes K, Faden AI. Multifunctional drug treatment in neurotrauma. Neurotherapeutics. 2009;6(1):14\u201327.","journal-title":"Neurotherapeutics"},{"key":"2383_CR40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fneur.2017.00744","volume":"8","author":"J Bhatti","year":"2018","unstructured":"Bhatti J, Nascimento B, Akhtar U, Rhind SG, Tien H, Nathens A, et al. Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation. Front Neurol. 2018;8:744.","journal-title":"Front Neurol"},{"issue":"9","key":"2383_CR41","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Singh TG, Kaur A. Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. J Mol Neurosci. 2021;71(9):1725\u201342.","journal-title":"J Mol Neurosci"},{"issue":"6","key":"2383_CR42","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/joim.12900","volume":"285","author":"N Marklund","year":"2019","unstructured":"Marklund N, Bellander BM, Godbolt AK, Levin H, McCrory P, Thelin EP. Treatments and rehabilitation in the acute and chronic state of traumatic brain injury. J Intern Med. 2019;285(6):608\u201323.","journal-title":"J Intern Med"},{"issue":"4","key":"2383_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10571-016-0400-1","volume":"37","author":"ML Pearn","year":"2017","unstructured":"Pearn ML, Niesman IR, Egawa J, Sawada A, Almenar-Queralt A, Shah SB, et al. Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics. Cell Mol Neurobiol. 2017;37(4):571\u201385.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"2383_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biologics4020011","volume":"4","author":"KJ Habashy","year":"2024","unstructured":"Habashy KJ, Omais S, Haupt B, Sonabend AM, Ahuja CS. Cell-based therapies for the treatment of traumatic brain injury: promises and trajectories. Biologics. 2024;4(2):161\u201376.","journal-title":"Biologics"},{"key":"2383_CR45","unstructured":"National Academies of Sciences E. Medicine, Health, et al. In: Matney C, Bowman K, Berwick D, eds. Traumatic Brain Injury: A Roadmap for Accelerating Progress. Washington (DC): National Academies Press (US) Copyright 2022 by the National Academy of Sciences. All rights reserved.; 2022."},{"issue":"9","key":"2383_CR46","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.3390\/jcm12093283","volume":"12","author":"JK Yue","year":"2023","unstructured":"Yue JK, Deng H. Traumatic brain injury: contemporary challenges and the path to progress. J Clin Med. 2023;12(9):3283.","journal-title":"J Clin Med"},{"key":"2383_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00651","volume":"11","author":"AV Shindyapina","year":"2017","unstructured":"Shindyapina AV, Komarova TV, Sheshukova EV, Ershova NM, Tashlitsky VN, Kurkin AV, et al. The antioxidant cofactor alpha-lipoic acid may control endogenous formaldehyde metabolism in mammals. Front Neurosci. 2017;11:651.","journal-title":"Front Neurosci"},{"key":"2383_CR48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2013.03.020","volume":"61","author":"AL McLain","year":"2013","unstructured":"McLain AL, Cormier PJ, Kinter M, Szweda LI. Glutathionylation of \u03b1-ketoglutarate dehydrogenase: the chemical nature and relative susceptibility of the cofactor lipoic acid to modification. Free Radic Biol Med. 2013;61:161\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"2383_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/biom9080356","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Berkay Y\u0131lmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, et al. Insights on the use of \u03b1-lipoic acid for therapeutic purposes. Biomolecules. 2019;9(8):356.","journal-title":"Biomolecules"},{"issue":"1","key":"2383_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/0109298673300496240416114827","volume":"32","author":"M Shanaida","year":"2025","unstructured":"Shanaida M, Lysiuk R, Mykhailenko O, Hudz N, Abdulsalam A, Gontova T, et al. Alpha-lipoic acid: an antioxidant with anti-aging properties for disease therapy. Curr Med Chem. 2025;32(1):23\u201354.","journal-title":"Curr Med Chem"},{"issue":"10","key":"2383_CR51","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","volume":"1790","author":"KP Shay","year":"2009","unstructured":"Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149\u201360.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2383_CR52","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1007\/s12035-017-0813-y","volume":"55","author":"SE Fiedler","year":"2018","unstructured":"Fiedler SE, Yadav V, Kerns AR, Tsang C, Markwardt S, Kim E, et al. Lipoic acid stimulates cAMP production in healthy control and secondary progressive MS subjects. Mol Neurobiol. 2018;55(7):6037\u201349.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2383_CR53","first-page":"8409329","volume":"2019","author":"SM Dos Santos","year":"2019","unstructured":"Dos Santos SM, Romeiro CF, Rodrigues CA, Cerqueira AR, Monteiro MC. Mitochondrial dysfunction and alpha-lipoic acid: beneficial or harmful in Alzheimer\u2019s disease? Oxid Med Cell Longev. 2019;2019(1):8409329.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"2383_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/1028415X.2017.1386755","volume":"22","author":"F Seifar","year":"2019","unstructured":"Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A, et al. \u03b1-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: a review. Nutr Neurosci. 2019;22(5):306\u201316.","journal-title":"Nutr Neurosci"},{"key":"2383_CR55","unstructured":"Kratzer IM. Evaluation of therapeutically useful transport routes across the blood-brain barrier using synthetic and natural carrier systems\/Ingrid Kratzer.\u00a02009."},{"issue":"3","key":"2383_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/cns.13793","volume":"28","author":"H Xie","year":"2022","unstructured":"Xie H, Yang X, Cao Y, Long X, Shang H, Jia Z. Role of lipoic acid in multiple sclerosis. CNS Neurosci Ther. 2022;28(3):319\u201331.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"2383_CR57","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00011-017-1079-6","volume":"66","author":"D Tibullo","year":"2017","unstructured":"Tibullo D, Li Volti G, Giallongo C, Grasso S, Tomassoni D, Anfuso CD, et al. Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential. Inflamm Res. 2017;66(11):947\u201359.","journal-title":"Inflamm Res"},{"key":"2383_CR58","unstructured":"Marti Navia A. Role investigation of adenosine receptor ligands on neuroinflammation and neurodegenerative diseases. 2020."},{"issue":"6","key":"2383_CR59","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/medicina56060300","volume":"56","author":"H Deng","year":"2020","unstructured":"Deng H, Yue JK, Zusman BE, Nwachuku EL, Abou-Al-Shaar H, Upadhyayula PS, et al. B-cell lymphoma 2 (Bcl-2) and regulation of apoptosis after traumatic brain injury: a clinical perspective. Medicina (Kaunas). 2020;56(6):300.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"2383_CR60","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1111\/jcmm.14296","volume":"23","author":"D Xia","year":"2019","unstructured":"Xia D, Zhai X, Wang H, Chen Z, Fu C, Zhu M. Alpha lipoic acid inhibits oxidative stress-induced apoptosis by modulating of Nrf2 signalling pathway after traumatic brain injury. J Cell Mol Med. 2019;23(6):4088\u201396.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2383_CR61","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","volume":"14","author":"E Kiskinis","year":"2014","unstructured":"Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14(6):781\u201395.","journal-title":"Cell Stem Cell"},{"key":"2383_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.brainresbull.2018.05.019","volume":"140","author":"T Wang","year":"2018","unstructured":"Wang T, Cheng J, Wang S, Wang X, Jiang H, Yang Y, et al. \u03b1-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK\/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis. Brain Res Bull. 2018;140:299\u2013310.","journal-title":"Brain Res Bull"},{"issue":"4","key":"2383_CR63","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","volume":"63","author":"A Gor\u0105ca","year":"2011","unstructured":"Gor\u0105ca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B. Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep. 2011;63(4):849\u201358.","journal-title":"Pharmacol Rep"},{"issue":"3","key":"2383_CR64","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijerph20032358","volume":"20","author":"GA Basile","year":"2023","unstructured":"Basile GA, Iannuzzo F, Xerra F, Genovese G, Pandolfo G, Cedro C, et al. Cognitive and mood effect of Alpha-Lipoic acid supplementation in a nonclinical elder sample: an open-label pilot study. Int J Environ Res Public Health. 2023;20(3):2358.","journal-title":"Int J Environ Res Public Health"},{"key":"2383_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2012.12.041","volume":"1499","author":"Y Koriyama","year":"2013","unstructured":"Koriyama Y, Nakayama Y, Matsugo S, Kato S. Protective effect of lipoic acid against oxidative stress is mediated by Keap1\/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline. Brain Res. 2013;1499:145\u201357.","journal-title":"Brain Res"},{"issue":"2","key":"2383_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/187153008784534303","volume":"8","author":"S Salinthone","year":"2008","unstructured":"Salinthone S, Yadav V, Bourdette DN, Carr DW. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr Metab Immune Disord Drug Targets. 2008;8(2):132\u201342.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"2383_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ijms18030504","volume":"18","author":"KK Thompson","year":"2017","unstructured":"Thompson KK, Tsirka SE. The diverse roles of microglia in the neurodegenerative aspects of central nervous system (CNS) autoimmunity. Int J Mol Sci. 2017;18(3):504.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2383_CR68","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1021\/jf0702693","volume":"55","author":"J Ren","year":"2007","unstructured":"Ren J, Chung SH. Anti-inflammatory effect of \u03b1-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NF-kappaB and mitogen-activated protein kinase pathways. J Agric Food Chem. 2007;55(13):5073\u201380.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2383_CR69","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s10753-014-9957-3","volume":"38","author":"G Li","year":"2015","unstructured":"Li G, Fu J, Zhao Y, Ji K, Luan T, Zang B. Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-\u03baB) signaling pathway. Inflammation. 2015;38(2):510\u20139.","journal-title":"Inflammation"},{"issue":"1","key":"2383_CR70","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12031-012-9884-4","volume":"50","author":"J Deslauriers","year":"2013","unstructured":"Deslauriers J, Desmarais C, Sarret P, Grignon S. \u03b1-lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt\/GSK-3\u03b2 signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia. J Mol Neurosci. 2013;50(1):134\u201345.","journal-title":"J Mol Neurosci"},{"issue":"1\u20132","key":"2383_CR71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neures.2013.07.001","volume":"77","author":"Y Koriyama","year":"2013","unstructured":"Koriyama Y, Nakayama Y, Matsugo S, Sugitani K, Ogai K, Takadera T, et al. Anti-inflammatory effects of lipoic acid through inhibition of GSK-3\u03b2 in lipopolysaccharide-induced BV-2 microglial cells. Neurosci Res. 2013;77(1\u20132):87\u201396.","journal-title":"Neurosci Res"},{"issue":"2","key":"2383_CR72","first-page":"246","volume":"8","author":"X Zhou","year":"2016","unstructured":"Zhou X, Li Y, Shi X, Ma C. An overview on therapeutics attenuating amyloid \u03b2 level in Alzheimer\u2019s disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. Am J Transl Res. 2016;8(2):246\u201369.","journal-title":"Am J Transl Res"},{"issue":"7","key":"2383_CR73","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s11064-022-03598-w","volume":"47","author":"H Khan","year":"2022","unstructured":"Khan H, Singh TG, Dahiya RS, Abdel-Daim MM. \u0391-lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective. Neurochem Res. 2022;47(7):1853\u201364.","journal-title":"Neurochem Res"},{"issue":"1","key":"2383_CR74","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1021\/acs.nanolett.9b04216","volume":"20","author":"L Xiao","year":"2020","unstructured":"Xiao L, Wei F, Zhou Y, Anderson GJ, Frazer DM, Lim YC, et al. Dihydrolipoic acid-gold nanoclusters regulate microglial polarization and have the potential to alter neurogenesis. Nano Lett. 2020;20(1):478\u201395.","journal-title":"Nano Lett"},{"issue":"4","key":"2383_CR75","doi-asserted-by":"publisher","first-page":"573","DOI":"10.46871\/eams.1346139","volume":"4","author":"I Bulama","year":"2024","unstructured":"Bulama I, Saidu UF, Suleiman N, Abbas A, Saidu Y, Yakubu Y, et al. Antioxidative strategy in traumatic brain injury: role of low-molecular-weight antioxidants. Exp Appl Med Sci. 2024;4(4):573\u201394.","journal-title":"Exp Appl Med Sci"},{"issue":"3","key":"2383_CR76","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s11064-009-0072-z","volume":"35","author":"M Er\u015fahin","year":"2010","unstructured":"Er\u015fahin M, Toklu HZ, \u00c7etinel S, Y\u00fcksel M, Erzik C, Berkman MZ, et al. Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage. Neurochem Res. 2010;35(3):418\u201328.","journal-title":"Neurochem Res"},{"issue":"5","key":"2383_CR77","first-page":"666","volume":"30","author":"H Kul","year":"2020","unstructured":"Kul H, Celik H, Kurtulus A, Tekiner A, Erdem Y, Kul G, et al. The effect of alpha lipoic acid on cerebrospinal fluid biochemistry and brain Edema after experimental traumatic brain injury. Turk Neurosurg. 2020;30(5):666\u201372.","journal-title":"Turk Neurosurg"},{"issue":"6","key":"2383_CR78","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.trsl.2015.08.005","volume":"166","author":"BP Lucke-Wold","year":"2015","unstructured":"Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, et al. Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury. Transl Res. 2015;166(6):509-528.e1.","journal-title":"Transl Res"},{"issue":"2","key":"2383_CR79","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2004.03.019","volume":"1016","author":"JL Meyerhoff","year":"2004","unstructured":"Meyerhoff JL, Lee JK, Rittase BW, Tsang AY, Yourick DL. Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res. 2004;1016(2):139\u201344.","journal-title":"Brain Res"},{"issue":"3","key":"2383_CR80","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/10520295.2014.977950","volume":"90","author":"S Ozbal","year":"2015","unstructured":"Ozbal S, Cankurt U, Tugyan K, Pekcetin C, Sisman AR, Gunduz K, et al. The effects of \u03b1-lipoic acid on immature rats with traumatic brain injury. Biotech Histochem. 2015;90(3):206\u201315.","journal-title":"Biotech Histochem"},{"issue":"3","key":"2383_CR81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/02699052.2014.973448","volume":"29","author":"S Paradells","year":"2015","unstructured":"Paradells S, Zipancic I, Mart\u00ednez-Losa MM, Garc\u00eda Esparza M\u00c1, Bosch-Morell F, Alvarez-Dolado M, et al. Lipoic acid and bone marrow derived cells therapy induce angiogenesis and cell proliferation after focal brain injury. Brain Inj. 2015;29(3):380\u201395.","journal-title":"Brain Inj"},{"issue":"7","key":"2383_CR82","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/10715760902988843","volume":"43","author":"HZ Toklu","year":"2009","unstructured":"Toklu HZ, Hakan T, Biber N, Solako\u011flu S, O\u011f\u00fcn\u00e7 AV, Sener G. The protective effect of alpha lipoic acid against traumatic brain injury in rats. Free Radic Res. 2009;43(7):658\u201367.","journal-title":"Free Radic Res"},{"key":"2383_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuint.2015.06.003","volume":"87","author":"W Wei","year":"2015","unstructured":"Wei W, Wang H, Wu Y, Ding K, Li T, Cong Z, et al. Alpha lipoic acid inhibits neural apoptosis via a mitochondrial pathway in rats following traumatic brain injury. Neurochem Int. 2015;87:85\u201391.","journal-title":"Neurochem Int"},{"issue":"1","key":"2383_CR84","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13054-016-1318-1","volume":"20","author":"N Stocchetti","year":"2016","unstructured":"Stocchetti N, Zanier ER. Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review. Crit Care. 2016;20(1):148.","journal-title":"Crit Care"},{"issue":"9","key":"2383_CR85","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40263-016-0355-2","volume":"30","author":"SE Gruenbaum","year":"2016","unstructured":"Gruenbaum SE, Zlotnik A, Gruenbaum BF, Hersey D, Bilotta F. Pharmacologic neuroprotection for functional outcomes after traumatic brain injury: a systematic review of the clinical literature. CNS Drugs. 2016;30(9):791\u2013806.","journal-title":"CNS Drugs"},{"issue":"3","key":"2383_CR86","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/acschemneuro.6b00306","volume":"8","author":"S Paradells-Navarro","year":"2017","unstructured":"Paradells-Navarro S, Benlloch-Navarro MS, Almansa Frias MI, Garcia-Esparza MA, Broccoli V, Miranda M, et al. Neuroprotection of brain cells by lipoic acid treatment after cellular stress. ACS Chem Neurosci. 2017;8(3):569\u201377.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"2383_CR87","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cbf.3163","volume":"34","author":"R Ma","year":"2016","unstructured":"Ma R, Wang X, Peng P, Xiong J, Dong H, Wang L, et al. \u0391-lipoic acid inhibits sevoflurane-induced neuronal apoptosis through PI3K\/Akt signalling pathway. Cell Biochem Funct. 2016;34(1):42\u20137.","journal-title":"Cell Biochem Funct"},{"key":"2383_CR88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tice.2017.12.001","volume":"50","author":"H Zhao","year":"2018","unstructured":"Zhao H, Bu M, Li B, Zhang Y. Lipoic acid inhibited desflurane-induced hippocampal neuronal apoptosis through Caspase3 and NF-KappaB dependent pathway. Tissue Cell. 2018;50:37\u201342.","journal-title":"Tissue Cell"},{"issue":"5","key":"2383_CR89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2174\/1568026615666150114161358","volume":"15","author":"FA Moura","year":"2015","unstructured":"Moura FA, de Andrade KQ, dos Santos JC, Goulart MO. Lipoic Acid: its antioxidant and anti-inflammatory role and clinical applications. Curr Top Med Chem. 2015;15(5):458\u201383.","journal-title":"Curr Top Med Chem"},{"issue":"13\u201314","key":"2383_CR90","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","volume":"60","author":"A Maczurek","year":"2008","unstructured":"Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer\u2019s disease. Adv Drug Deliv Rev. 2008;60(13\u201314):1463\u201370.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02383-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02383-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02383-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:01:36Z","timestamp":1775505696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02383-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2383"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02383-1","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}